Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06392854
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-04-24
Brief Title:
Regional Lipolysis Insulin Regulation
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Insulin Regulation of Regional Lipolysis
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Adults who gain most of their excess weight in the abdominal area typically do not respond to insulin in the same way as lean adults Researchers are trying to understand why fat tissue responds differently in people with different body types
Detailed Description:
Measure regional free fatty acid FFA release in volunteers with and without UBO under two different conditions that suppress lipolysis and a condition that markedly stimulates lipolysis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01DK040484 | NIH | None | httpsreporternihgovquickSearchR01DK040484 |